Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

Zineb Belcaid; Cor Berrevoets; John Choi; Edward van Beelen; Eftychia Stavrakaki; Tessa Pierson; Jenneke Kloezeman; Denis Routkevitch; Mariëlle van der Kaaij; Alicia van der Ploeg; Dimitrios Mathios; Stefan Sleijfer; Clemens Dirven; Michael Lim; Reno Debets; Martine L M Lamfers

doi:10.1093/noajnl/vdaa011

Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

Zineb Belcaid, Cor Berrevoets, John Choi, Edward van Beelen, Eftychia Stavrakaki, Tessa Pierson, Jenneke Kloezeman, Denis Routkevitch, Mariëlle van der Kaaij, Alicia van der Ploeg, Dimitrios Mathios, Stefan Sleijfer, Clemens Dirven, Michael Lim, Reno Debets, Martine L M Lamfers

Research output: Contribution to journal › Article › Academic › peer-review

17 Citations (Scopus)

2 Downloads (Pure)

Original language	Undefined/Unknown
Pages (from-to)	1-12
Journal	Neuro-oncology advances
Volume	2
Issue number	1
DOIs	https://doi.org/10.1093/noajnl/vdaa011
Publication status	Published - 3 Feb 2020

Access to Document

10.1093/noajnl/vdaa011Licence: CC BY

pmc7212906?pdf=renderFinal published version, 409 KBLicence: CC BY

Cite this

Belcaid, Z., Berrevoets, C., Choi, J., van Beelen, E., Stavrakaki, E., Pierson, T., Kloezeman, J., Routkevitch, D., van der Kaaij, M., van der Ploeg, A., Mathios, D., Sleijfer, S., Dirven, C., Lim, M., Debets, R., & Lamfers, M. L. M. (2020). Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy. Neuro-oncology advances, 2(1), 1-12. https://doi.org/10.1093/noajnl/vdaa011

@article{34e5301799104ed78af33d777a7e84fe,

title = "Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy",

author = "Zineb Belcaid and Cor Berrevoets and John Choi and {van Beelen}, Edward and Eftychia Stavrakaki and Tessa Pierson and Jenneke Kloezeman and Denis Routkevitch and {van der Kaaij}, Mari{\"e}lle and {van der Ploeg}, Alicia and Dimitrios Mathios and Stefan Sleijfer and Clemens Dirven and Michael Lim and Reno Debets and Lamfers, {Martine L M}",

year = "2020",

month = feb,

day = "3",

doi = "10.1093/noajnl/vdaa011",

language = "Undefined/Unknown",

volume = "2",

pages = "1--12",

number = "1",

}

Belcaid, Z , Berrevoets, C, Choi, J, van Beelen, E, Stavrakaki, E, Pierson, T, Kloezeman, J, Routkevitch, D, van der Kaaij, M, van der Ploeg, A, Mathios, D, Sleijfer, S , Dirven, C, Lim, M, Debets, R & Lamfers, MLM 2020, 'Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy', Neuro-oncology advances, vol. 2, no. 1, pp. 1-12. https://doi.org/10.1093/noajnl/vdaa011

TY - JOUR

T1 - Low-dose oncolytic adenovirus therapy overcomes tumor-induced immune suppression and sensitizes intracranial gliomas to anti-PD-1 therapy

AU - Belcaid, Zineb

AU - Berrevoets, Cor

AU - Choi, John

AU - van Beelen, Edward

AU - Stavrakaki, Eftychia

AU - Pierson, Tessa

AU - Kloezeman, Jenneke

AU - Routkevitch, Denis

AU - van der Kaaij, Mariëlle

AU - van der Ploeg, Alicia

AU - Mathios, Dimitrios

AU - Sleijfer, Stefan

AU - Dirven, Clemens

AU - Lim, Michael

AU - Debets, Reno

AU - Lamfers, Martine L M

PY - 2020/2/3

Y1 - 2020/2/3

U2 - 10.1093/noajnl/vdaa011

DO - 10.1093/noajnl/vdaa011

M3 - Article

VL - 2

SP - 1

EP - 12

IS - 1

ER -